H. Portier

3.8k total citations
112 papers, 2.6k citations indexed

About

H. Portier is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, H. Portier has authored 112 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Infectious Diseases, 50 papers in Epidemiology and 21 papers in Pharmacology. Recurrent topics in H. Portier's work include Pneumonia and Respiratory Infections (28 papers), HIV/AIDS drug development and treatment (20 papers) and Antibiotics Pharmacokinetics and Efficacy (20 papers). H. Portier is often cited by papers focused on Pneumonia and Respiratory Infections (28 papers), HIV/AIDS drug development and treatment (20 papers) and Antibiotics Pharmacokinetics and Efficacy (20 papers). H. Portier collaborates with scholars based in France, United States and Switzerland. H. Portier's co-authors include P. Chavanet, Lionel Piroth, Michel Duong, Michèle Grappin, Marielle Buisson, P. Dellamonica, J Modaï, Jean Lang, Patrice Massip and Y Mouton and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

H. Portier

107 papers receiving 2.5k citations

Peers

Countries citing papers authored by H. Portier

Since Specialization

Citations

This map shows the geographic impact of H. Portier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Portier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Portier more than expected).

Fields of papers citing papers by H. Portier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Portier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Portier. The network helps show where H. Portier may publish in the future.

Co-authorship network of co-authors of H. Portier

This figure shows the co-authorship network connecting the top 25 collaborators of H. Portier. A scholar is included among the top collaborators of H. Portier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Portier. H. Portier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Concentration of Circulating Oxidized LDL in HIV-Infected Patients Treated with Antiretroviral Agents: Relation to HIV-Related Lipodystrophy 2006 ·HIV Clinical Trials ·Michel Duong, Jean Michel Petit, Benoît Martha, F. Galland, Lionel Piroth, (unknown), Michèle Grappin, Marielle Buisson, Laurence Duvillard, P. Chavanet, H. Portier	35
2	In-vivo impact of the MexXY efflux system on aminoglycoside efficacy in an experimental model of Pseudomonas aeruginosa pneumonia treated with tobramycin 2006 ·Clinical Microbiology and Infection ·B. Martha, Delphine Croisier, David Durand, Didier Hocquet, Patrick Plésiat, Lionel Piroth, H. Portier, P. Chavanet	6
3	Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors 2005 ·European Journal of Clinical Microbiology & Infectious Diseases ·H. Portier, Christian Brambilla, M Garré, Fabrice Paganin, P. Poubeau, P. Zück	38
4	Les patients infectés par le virus de l'immunodéficience humaine sous traitement antirétroviral ont-ils un risque cardiovasculaire accru ? 2003 ·Annales de Cardiologie et d Angéiologie ·Michel Duong, Yves Cottin, Marie Froidure, J. Petit, Lionel Piroth, Marianne Zeller, Isabelle L’Huillier, (unknown), (unknown), P. Chavanet, Jean‐Eric Wolf, H. Portier	1
5	LDL‐receptors expression in HIV‐infected patients: relations to antiretroviral therapy, hormonal status, and presence of lipodystrophy 2002 ·European Journal of Clinical Investigation ·Jean‐Michel Petit, Michel Duong, Laurence Duvillard, E Florentin, H. Portier, Gérard Lizard, (unknown), Philippe Gambert, (unknown)	21
6	The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients 2002 ·Journal of Hepatology ·Lionel Piroth, Christine Binquet, (unknown), Anne Minello, (unknown), Jean‐Baptiste Bour, Marielle Buisson, Michel Duong, Michèle Grappin, H. Portier, P. Chavanet	89
7	Traitement des angines aiguës à streptocoque β-hémolytique du groupe A chez l’enfant par la josamycine pendant cinq jours 2001 ·Archives de Pédiatrie ·H. Portier, A Bourrillon, F. Lucht, P. Choutet, P Géhanno, (unknown), Édouard Bingen	12
8	Association Between Insulin Resistance and Hepatitis C Virus Chronic Infection in HIV–Hepatitis C Virus–Coinfected Patients Undergoing Antiretroviral Therapy 2001 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Michel Duong, Jean Michel Petit, Lionel Piroth, Michèle Grappin, Marielle Buisson, P. Chavanet, Patrick Hillon, H. Portier	98
9	Coronary heart disease associated with the use of human immunodeficiency virus (HTV)‐1 protease inhibitors: Report of four cases and review 2001 ·Clinical Cardiology ·Michel Duong, Marielle Buisson, Yves Cottin, Lionel Piroth, Isabelle L’Huillier, Michèle Grappin, P. Chavanet, (unknown), H. Portier	23
10	Efficacy of 5-day cefpodoxime proxetil for recurrent pharyngitis in adults. A comparative study with 10-day penicillin V or amoxycillin—clavulanate 1997 ·Clinical Microbiology and Infection ·H. Portier, P Géhanno, Philippe Weber, H. Dabernat, (unknown), (unknown), (unknown)	4
11	Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres 1997 ·AIDS ·Y Mouton, S. Alfandari, M. Valette, F Cartier, P. Dellamonica, Guy Humbert, Jean Lang, Patrice Massip, D. Méchali, Pascale Leclercq, J Modaï, H. Portier	313
12	Toxicity and efficacy of conventional amphotericin B deoxycholate versus escalating doses of amphotericin B deoxycholate—fat emulsion in HIV-infected patients with oral candidosis 1997 ·Clinical Microbiology and Infection ·P. Chavanet, (unknown), Michel Duong, Marielle Buisson, Philippe d’Athis, Monique Dumas, Alain Bonnin, H. Portier	12
13	Nasopharyngeal lymphomas: Further evidence for a natural killer cell origin 1996 ·Human Pathology ·Tony Petrella, Marie‐Hélène Delfau‐Larue, Denis Caillot, (unknown), Olivier Casasnovas, H. Portier, Philippe Gaulard, Jean‐Pierre Farcet, Laurent Arnould	24
14	6-Day Amoxicillin Versus 10-day Penicillin V for Group A β-Haemolytic Streptococcal Acute Tonsillitis in Adults: A French Multicentre, Open-label, Randomized Study 1996 ·Scandinavian Journal of Infectious Diseases ·D. Peyramond, H. Portier, Pierre Geslin, Robert Cohen	33
15	Five Versus Ten Days Treatment of Streptococcal Pharyngotonsillitis: A Randomized Controlled Trial Comparing Cefpodoxime Proxetil and Phenoxymethyl Penicillin 1994 ·Scandinavian Journal of Infectious Diseases ·H. Portier, P. Chavanet, (unknown), (unknown), (unknown), (unknown), (unknown)	54
16	Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro–in vivo correlation in HIV-infected patients 1994 ·AIDS ·(unknown), José Luis López‐Pérez, Michèle Grappin, Alain Bonnin, Michel Duong, Anne Waldner, (unknown), P. Camerlynck, H. Portier	69
17	High Concentrations of Intrathecal Interleukin-6 in Human Bacterial and Nonbacterial Meningitis 1992 ·The Journal of Infectious Diseases ·P. Chavanet, Bernard Bonnotte, Michel Guiguet, (unknown), Éric Solary, (unknown), Olivier Casasnovas, Denis Caillot, (unknown), (unknown), H. Portier	56
18	Five day treatment of pharyngotonsillitis with cefpodoxime proxetil 1990 ·Journal of Antimicrobial Chemotherapy ·H. Portier, P. Chavanet, Jean-Baptiste Gouyon, (unknown)	60
19	Successful plasma exchange in type 1 leprosy reversal reaction. 1984 ·BMJ ·F. Lucht, G Rifle, H. Portier, J.M. Chalopin, Julien Bonhomme	0
20	Epidemiology of brucellosis. 1978 ·Bulletin de l Académie Nationale de Médecine ·(unknown), H. Portier	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact